Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Finasteride does not cause sexual dysfunction in men with hair loss.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Post-finasteride syndrome causes various symptoms in men using finasteride, with no known cure.

Finasteride can double the risk of sexual problems like ejaculation issues, low libido, and impotence.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Finasterid 1mg, used for male hair loss, can cause sexual problems in some men, which can last for several months even after stopping the medication.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Finasteride can cause serious side effects in some men, needing more research for treatment.

Finasteride works best in 6 months and lasts 6 years.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Finasteride may cause side effects; more research needed.